Studies have shown that active fund managers routinely underperform the S&P500 index*​

West Pharmaceutical Services, Inc. (NYSE: WST)

WST Stock Predictions and Ratings

WSX Rating:
HOLD
WSX Forecast (1yr):
1.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-47%

WST Stock Analysis

WST PE Ratio: 42.3

WST PEG Ratio: 3.9

WST Forward EPS Growth (12 month): 10.80%

WST PS Ratio: 6.9

WST PSG Ratio: 1.1

WST Forward Revenue Growth (12 month): 6.10%

WST Articles

No data was found